enkephalinamide-met, ala(2)- has been researched along with Diabetes Mellitus in 1 studies
*Diabetes Mellitus: A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amir, LH; Crawford, SB; Forster, DA; Moorhead, AM | 1 |
1 trial(s) available for enkephalinamide-met, ala(2)- and Diabetes Mellitus
| Article | Year |
|---|---|
'Is there any point in me doing this?' Views and experiences of women in the Diabetes and Antenatal Milk Expressing (DAME) trial.
Topics: Breast Feeding; Diabetes Mellitus; Enkephalin, Methionine; Female; Humans; Infant; Milk, Human; Pregnancy; Prenatal Care; Qualitative Research | 2022 |